Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
 GILD | Gilead Sciences Inc | $161.7b | $130.47 | 0.0% | 3.2K |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.8b | $6.25 | 0.0% | 153.3K |
 NTLA | Intellia Therapeutics, Inc | $1.5b | $11.58 | 0.0% | 23.9K |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $9.43 | 0.0% | 1 |
 VOR | Vor Biopharma Inc. Common Stock | $1.2b | $23.79 | 0.0% | 624 |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $3.32 | 0.0% | 1.8K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.6b | $1.95 | 0.0% | 8 |
 IMMX | Immix Biopharma, Inc. Common Stock | $0.6b | $10.23 | 0.0% | 7.7K |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $490.7m | $11.65 | 0.0% | N/A |
 IPSC | Century Therapeutics, Inc. Common Stock | $364.3m | $1.97 | 0.0% | 5 |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $317.1m | $14.19 | 0.0% | N/A |
 FATE | Fate Therapeutics, Inc. | $285.6m | $2.50 | 0.0% | 305 |
 TARA | Protara Therapeutics, Inc. Common Stock | $214.1m | $4.21 | 0.0% | 23 |
 YDES | YD Bio Limited Ordinary Shares | $162.9m | $2.31 | 0.0% | N/A |
 NKTX | Nkarta, Inc. Common Stock | $153.8m | $2.29 | 0.0% | N/A |
 CRBU | Caribou Biosciences, Inc. Common Stock | $144.8m | $1.63 | 0.0% | 1.1K |
 ENGN | enGene Therapeutics Inc. Common Stock | $119.9m | $1.79 | 0.0% | N/A |
 ANIX | Anixa Biosciences, Inc. | $116.4m | $3.48 | 0.0% | 5 |
 ACET | Adicet Bio, Inc. Common Stock | $85.2m | $8.45 | 0.0% | 389 |
 ATRA | Atara Biotherapeutics, Inc | $75.5m | $8.35 | 0.0% | 240 |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 105.9K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $52.3m | $11.23 | 0.0% | 97 |
 TCRX | TScan Therapeutics, Inc. Common Stock | $47.3m | $0.78 | 0.0% | N/A |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $30.7m | $0.74 | 0.0% | 2 |
 TVGN | Tevogen Inc. Common Stock | $29.6m | $6.71 | 0.0% | 20 |
 CELU | Celularity Inc. Class A Common Stock | $18.4m | $0.68 | 0.0% | N/A |
 SNTI | Senti Biosciences Holdings, Inc. Common Stock | $11.5m | $0.39 | 0.0% | 178 |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $11.0m | $0.88 | 0.0% | 1.1K |
 INAB | IN8bio, Inc. Common Stock | $10.2m | $0.99 | 0.0% | 100 |
 LNAI | Lunai Bioworks Inc. Common Stock | $8.8m | $2.38 | 0.0% | 358 |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $6.2m | $0.59 | 0.0% | 280 |
 MBIO | Mustang Bio, Inc. | $4.4m | $0.59 | 0.0% | 2.0K |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $3.8m | $4.25 | 0.0% | 507 |
 CLDI | Calidi Biotherapeutics, Inc. | $2.0m | $1.79 | -0.6% | 20.3K |